Clinical Trial Update: A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating mericitabine with boceprevir and Pegasys/Copegus in chronic hepatitis C has completed. The update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)
• Copegus (ribavirin)
• Mericitabine (mericitabine)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED